During the past decade, ClinicMed Badurski i wspolnicy Spolka Jawna conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 19 clinical trials were completed, i.e. on average, 70.4% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 16 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ClinicMed Badurski i wspolnicy Spolka Jawna" #1 sponsor was "Pfizer" with 8 trials, followed by "Bristol-Myers Squibb" with 4 trials sponsored, "Abivax S.A." with 2 trials sponsored, "Amgen" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ClinicMed Badurski i wspolnicy Spolka Jawna" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "TIMI Study Group" with 1 trials as a collaborator and "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "ClinicMed Badurski i wspolnicy Spolka Jawna" are "Rheumatoid Arthritis" (7 trials), "Arthritis, Psoriatic" (3 trials), "Osteoarthritis, Knee" (3 trials), "Psoriasis" (3 trials) and "Osteoarthritis, Hip" (2 trials). Many other conditions were trialed in "ClinicMed Badurski i wspolnicy Spolka Jawna" in a lesser frequency.

Most popular intervention types in "ClinicMed Badurski i wspolnicy Spolka Jawna" are "Drug" (28 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Methotrexate" (4 trials), "Adalimumab" (2 trials), "BMS-986165" (2 trials) and "CP-690,550" (2 trials). Other intervention names were less common.

The vast majority of trials in "ClinicMed Badurski i wspolnicy Spolka Jawna" are 26 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "ClinicMed Badurski i wspolnicy Spolka Jawna". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in ClinicMed Badurski i wspolnicy Spolka Jawna, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ClinicMed Badurski i wspolnicy Spolka Jawna, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".